Related Experiment Video

Updated: May 24, 2026

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms

Kyeong-A Kim1, Young-Jun Shin, Jeong-Hyeon Kim

  • 1College of Pharmacy, Hanyang University, Gyeonggi-do 426-791, Korea.

Archives of Pharmacal Research
|February 29, 2012
PubMed

Insights

Diabetic patients experience impaired angiogenesis due to dysfunctional endothelial progenitor cells (EPCs), leading to cardiovascular issues. Understanding these dysfunctions is key for developing effective cell therapies for diabetes complications.

Area of Science:

  • Cardiovascular Medicine
  • Diabetology
  • Stem Cell Biology

Background:

  • Cardiovascular complications are a leading cause of mortality in diabetes.
  • Impaired angiogenesis in diabetes contributes to delayed wound healing and limb amputation.
  • Endothelial progenitor cells (EPCs) are crucial for vascular repair and neovascularization.

Purpose of the Study:

  • To review clinical evidence of impaired EPC function in diabetic patients.
  • To discuss the underlying mechanisms contributing to diabetic EPC dysfunction.
  • To explore the implications for EPC-based cell therapy in diabetes.

Main Methods:

  • Literature review of clinical studies on EPCs in diabetic conditions.
  • Analysis of proposed mechanisms for diabetic EPC dysfunction.
  • Synthesis of evidence regarding EPC recruitment and function.

Main Results:

  • Diabetic conditions are associated with reduced numbers and impaired function of EPCs.
  • Key mechanisms include increased oxidative stress, inflammation, nitric oxide pathway alterations, and reduced EPC recruitment signals.
  • Diabetic EPC dysfunction contributes to defective angiogenesis and cardiovascular complications.

Conclusions:

  • Diabetic EPC dysfunction is a significant factor in diabetes-related cardiovascular complications.
  • Understanding these mechanisms is vital for advancing EPC cell therapy for diabetic patients.
  • Further research is needed to fully elucidate and target these pathways for therapeutic benefit.

More Related Videos

Decellularization and Recellularization Methodology for Human Saphenous Veins11:35

Decellularization and Recellularization Methodology for Human Saphenous Veins

Published on: July 27, 2018

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...